WAVE LIFE SCIENCES LTD. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.475 USD | +1.49% |
|
+12.84% | +30.50% |
| 05-15 | Wells Fargo Starts WAVE Life Sciences With Overweight Rating, $11 Price Target | MT |
| 05-09 | Transcript : Wave Life Sciences Ltd., Q1 2024 Earnings Call, May 09, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 781M | - | - | ||||
| 115B | ||||||
| 107B | ||||||
| 22.31B | - | |||||
| 21.6B | - | |||||
| 18.23B | - |
